Robert W. Peabody

2015 - Oncocyte Corp

In 2015, Robert W. Peabody earned a total compensation of $296K as Former Chief Financial Officer at Oncocyte Corp, a 441% increase compared to previous year.

Compensation breakdown

Bonus$6,750
Option Awards$197,356
Salary$57,454
Other$34,460
Total$296,020

Peabody received $197.4K in option awards, accounting for 67% of the total pay in 2015.

Peabody also received $6.8K in bonus, $57.5K in salary and $34.5K in other compensation.

Rankings

In 2015, Robert W. Peabody's compensation ranked 12,385th out of 13,638 executives tracked by ExecPay. In other words, Peabody earned more than 9.2% of executives.

ClassificationRankingPercentile
All
12,385
out of 13,638
9th
Division
Manufacturing
4,740
out of 5,190
9th
Major group
Chemicals And Allied Products
1,726
out of 1,854
7th
Industry group
Drugs
1,429
out of 1,528
7th
Industry
In Vitro and In Vivo Diagnostic Substances
71
out of 76
7th
Source: SEC filing on April 29, 2016.

Peabody's colleagues

We found six more compensation records of executives who worked with Robert W. Peabody at Oncocyte Corp in 2015.

2015

William Annett

Oncocyte Corp

Chief Executive Officer

2015

Karen Chapman

Oncocyte Corp

VP of Research

2015

Alfred Kingsley

Oncocyte Corp

Chairman

2015

Kristine Mechem

Oncocyte Corp

VP of Marketing

2015

Joseph Wagner

Oncocyte Corp

Chief Executive Officer

2015

Lyndal Hesterberg

Oncocyte Corp

Senior VP of Research and Development

In-depth

You may also like